NovelStem International Corp. (NSTM)

OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
At close: Mar 2, 2026
-9.09%
Market Cap 468.82K
Revenue (ttm) 3.00K
Net Income (ttm) 2.31M
Shares Out 46.88M
EPS (ttm) 0.05
PE Ratio 0.20
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,000
Average Volume 98,105
Open 0.0100
Previous Close n/a
Day's Range 0.0100 - 0.0100
52-Week Range 0.0081 - 0.0394
Beta 2.31
RSI 44.54
Earnings Date Apr 2, 2026

About NovelStem International

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida. [Read more]

Sector Healthcare
Founded 1993
Employees 15
Stock Exchange OTCMKTS
Ticker Symbol NSTM
Full Company Profile

Financial Performance

In 2024, NovelStem International's revenue was $12,000, a change of 0.00% compared to the previous year's $12,000. Losses were -$3.23 million, -22.79% less than in 2023.

Financial Statements

News

There is no news available yet.